What happens if cannabis moves to a lower-risk drug tier?

A recent recommendation from U.S. health officials could move marijuana from a Schedule I substance to a Schedule III substance before the end of the year. Perhaps the biggest impact of this move would be on the way cannabis businesses are taxed, as they’d no longer be subject to Internal Revenue Code 280E (IRC 280E). Lance Boldrey (leader of Dykema’s Cannabis group) and John Fraser (Michigan Team Leader of Dykema’s Cannabis group) are joined by Scott Kociensk of Dykema’s Federal Tax group to discuss the implications this could unlock for the industry.  Find more on Lance here.Find more on John here.Find more on Scott here.To hear more episodes, visit DykemaPodcast.com, our YouTube page, or search “A Higher Law” wherever you get your podcasts.Subscribe to Dykema’s Cannabis Law BlogLearn more about Dykema’s cannabis groupFollow Dykema on LinkedIn